Interdisciplinary databank in oncoendocrinology: radioiodine refractory differentiated thyroid cancer

Capa

Citar

Resumo

High achievements in personalized evidence-based medicine and oncology, particularly in developed countries, are associated with the successful development of “clinical” carceral registries of patients (SEER, NCDB, etc.), which are multimodal data banks. They are a data matrix for the development of analytical and prognostic tools in the study of diagnostic features, clinical disease course, therapy response, assessment of prognostic factors, etc. From the point of view of medical digital data banks, data redundancy and duplication are not as critical as information incompleteness or inconsistency when making medical decisions.

This study aimed to present a multimodal database of patients with radioiodine refractory differentiated thyroid cancer, which is essentially a modern interdisciplinary digital medical registry.

Along with demographic and nosological data that is typical for epidemiological registers, the multimodal data banks consider key clinical and paraclinical data, such as the results of laboratory, morphological, and instrumental research methods, and various imaging methods, such as ultrasound, computed tomography (CT), magnetic resonance imaging, single-photon emission computed tomography/CT, and positron emission tomography/CT. The multimodal data banks present the molecular genetic profile results of the tumor, of which the clinical usefulness in the choice of treatment tactics is undoubted today. All these data are accumulated in the multimodal data banks, noting the execution time and the revision results (second opinion), considering standardized qualitative and quantitative parameters (factors) that potentially affect the clinical course, treatment response, complication development, and outcomes.

Sobre autores

Pavel Rumyantsev

International Medical Center “SOGAZ-MEDICINE”

Email: pavelrum@gmail.com
ORCID ID: 0000-0002-7721-634X
Código SPIN: 7085-7976

MD, Dr.Sci. (Med), Deputy Director of Oncoendocrine Institute

Rússia, 8, Malaya Konyushennaya, Saints Peterburg, 191186

Andrey Baidak

M-Data

Autor responsável pela correspondência
Email: baidak@medical-data.ru
Rússia, Orel

Bibliografia

  1. Chissov VI, Starinsky VV, Petrova GV. Malignant neoplasms in Russia since 2008 (morbidity and mortality). Moscow: P.A. Herzen Federal State Medical Research Institute of Rosmedtechnology; 2010. 256 p. (In Russ).
  2. Kaprin AD, Starinsky VV, Petrova GV. The state of oncological care for the population of Russia in 2019. Moscow: P.A. Herzen Moscow State Medical Research Institute — branch of the FSBI NMIC of Radiology of the Ministry of Health of Russia,2020. 236 p. (In Russ).
  3. Pacini F, Fuhrer D, Elisei R, et al. 2022 ETA Consensus Statement: what are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? Eur Thyroid J. 2022;11(1):e210046. doi: 10.1530/ETJ-21-0046
  4. Rumyantsev PO, Fomin DK, Rumyantseva UV. Criteria of resistance of highly differentiated thyroid cancer to therapy with radioactive iodine. Tumors Head Neck. 2014;(3):4–9. (In Russ).
  5. Rumyantsev PO, Slashchuk KY, Korenev SV, et al. Interdisciplinary data bank in oncoendocrinology. Medullary thyroid cancer and syndromes of multiple endocrine neoplasia type 2. Endocrine Sur. 2019;13(3):105–117. (In Russ). doi: 10.14341/serg11270
  6. Almazov AA, Rumyantsev PO, Kupreev PP, et al. Medical decision support systems; analysis of multimodal data, the difference between “human” and “machine” approaches, social problems of collection and turnover of biomedical data. Doctor Information Technol. 2020;(2):28–35. (In Russ). doi: 10.37690/1811-0193-2020-2-28-35
  7. Gatta G, van der Zwan JM, Casali PG, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47(17):2493–2511. doi: 10.1016/j.ejca.2011.08.008
  8. Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(12):1856–1883. doi: 10.1093/annonc/mdz400
  9. Clinical recommendations “Differentiated thyroid cancer”. Moscow; 2020. 47 p. (In Russ).

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Rumyantsev P.O., Baidak A.G., 2022

Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição–NãoComercial–SemDerivações 4.0 Internacional.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies